<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>ROHDA, SANDIMARI Progress Note</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body><h1 class="h1center">ROHDA, SANDIMARI Progress Note</h1><table class="header_table"><tr><td class="td_header_role_name"><span class="td_label">Patient</span></td><td class="td_header_role_value">SANDIMARI P ROHDA</td></tr><tr><td class="td_header_role_name"><span class="td_label">Date of birth</span></td><td class="td_header_role_value">October 16, 1939 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Current Gender</span></td><td class="td_header_role_value">Female</td></tr><tr><td class="td_header_role_name"><span class="td_label">Race(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>WHITE</li><li>White</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Ethnicity</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>NOT HISPANIC OR LATINO</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Language(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>English</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Primary Home Address:<br/>2654 W HORIZON RIDGE PKWY<br/>STE B<br/>HENDERSON, NV 89052<br/><br/>Mobile Phone:  (480)993-4317<br/>Mobile Phone:  (480)993-4317<br/>Email:  glo4vinny@aol.com<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Patient IDs</span></td><td class="td_header_role_value">1524290 2.16.840.1.113883.3.623<br/></td></tr></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document Id</span></td><td class="td_header_role_value">ProgressNote_ROHDA_20240729_1350_22.665 2.16.840.1.113883.3.623</td></tr><tr><td class="td_header_role_name"><span class="td_label">Document Created:</span></td><td class="td_header_role_value">July 29, 2024, 13:50:22, MST </td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Rupesh J Parikh of Comprehensive Cancer Center of Nevada</td></tr><tr><td class="td_header_role_value internal_format"><br/><br/><br/></td></tr></tbody></table></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Author</span></td><td class="td_header_role_value">G2Carequality Interface, Comprehensive Cancer Center of Nevada</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">Siena Stephanie Horizon Ridge Twain<br/>Summerlin Southern Hills Northwest<br/>Las Vegas, NV 89128<br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Encounter Id</span></td><td class="td_header_role_value">9937012 2.16.840.1.113883.19</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Type</span></td><td class="td_header_role_value">OFFICE/OUTPATIENT ESTABLISHED MOD MDM 30-39 MIN</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Date</span></td><td class="td_header_role_value"> From December 20, 2022  to December 20, 2022 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Location</span></td><td class="td_header_role_value"/></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Informant</span></td><td class="td_header_role_value">Rupesh J Parikh of Comprehensive Cancer Center of Nevada</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document maintained by</span></td><td class="td_header_role_value">McKesson Specialty Health</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">10101 Woodloch Forest<br/>The Woodlands, TX 77380, USA<br/><br/>Work Phone:  800 381 2637<br/></td></tr></tbody></table><h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Assessment</a></li><li><a href="#id2">Allergies and Adverse Reactions</a></li><li><a href="#id3">Plan</a></li><li><a href="#id4">Reason for Visit</a></li><li><a href="#id5">Encounters</a></li><li><a href="#id6">Immunizations</a></li><li><a href="#id7">Diagnostic Results</a></li><li><a href="#id8">Medications</a></li><li><a href="#id9">Problems</a></li><li><a href="#id10">Vital Signs</a></li><li><a href="#id11">Notes Section</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Assessment</a></h3><div>See Clinical Notes section</div><h3><a name="id2" href="#toc">Allergies and Adverse Reactions</a></h3><div><table>
    <thead>
        <tr>
                            <th>Medication/Group Name</th>
                <th>Reaction</th>
                <th>Severity</th>
                <th>Date</th>
        </tr>
    </thead>
    <tbody>
                <tr ID="AlertOBS-1000">
                            <td>meperidine HCl</td>
                            <td>Rash</td>
                            <td/>
                            <td>07/22/2024</td>
                </tr>
                <tr ID="AlertOBS-1001">
                            <td>Adhesive tape</td>
                            <td>Rash</td>
                            <td/>
                            <td>07/22/2024</td>
                </tr>
                <tr ID="AlertOBS-1002">
                            <td>Steri-strips</td>
                            <td/>
                            <td/>
                            <td>07/22/2024</td>
                </tr>
                <tr ID="AlertOBS-1003">
                            <td>alcohol antiseptic pads</td>
                            <td/>
                            <td/>
                            <td>07/22/2024</td>
                </tr>
                <tr ID="AlertOBS-1004">
                            <td>baclofen</td>
                            <td>Rash</td>
                            <td/>
                            <td>07/22/2024</td>
                </tr>
                <tr ID="AlertOBS-1005">
                            <td>Benzodiazepines</td>
                            <td>Rash</td>
                            <td/>
                            <td>07/22/2024</td>
                </tr>
                <tr ID="AlertOBS-1006">
                            <td>Opioids-Meperidine and Related</td>
                            <td>Rash</td>
                            <td/>
                            <td>07/22/2024</td>
                </tr>
                <tr ID="AlertOBS-1007">
                            <td>Iodinated Contrast- Oral and IV Dye</td>
                            <td>Rash</td>
                            <td/>
                            <td>07/22/2024</td>
                </tr>
    </tbody>
</table>
</div><h3><a name="id3" href="#toc">Plan</a></h3><div><table>
	<thead>
		<tr>
							<th>Date</th>
				<th>Type</th>
				<th>Value</th>
		</tr>
	</thead>
	<tbody>
				<tr ID="CarePlanRef-1008">
						<td>01/24/2023</td>
						<td>APPOINTMENT</td>
						<td>NURSE DRAW 15 MIN</td>
				</tr>
				<tr ID="CarePlanRef-1009">
						<td>01/24/2023</td>
						<td>APPOINTMENT</td>
						<td>CHEMO LAB 15 MIN</td>
				</tr>
				<tr ID="CarePlanRef-1010">
						<td>01/18/2023</td>
						<td>APPOINTMENT</td>
						<td>PBR 15 MIN</td>
				</tr>
				<tr ID="CarePlanRef-1011">
						<td>12/20/2022</td>
						<td>APPOINTMENT</td>
						<td>INJECTION 15 MIN</td>
				</tr>
				<tr ID="CarePlanRef-1012">
						<td>12/20/2022</td>
						<td>APPOINTMENT</td>
						<td>OV 15 MIN</td>
				</tr>
				<tr ID="CarePlanRef-1013">
						<td>12/20/2022</td>
						<td>LABORDER</td>
						<td>U/S</td>
				</tr>
				<tr ID="CarePlanRef-1014">
						<td>01/24/2023</td>
						<td>LABORDER</td>
						<td>CBC w/ auto diff</td>
				</tr>
				<tr ID="CarePlanRef-1015">
						<td>01/24/2023</td>
						<td>LABORDER</td>
						<td>CA 27-29 panel</td>
				</tr>
				<tr ID="CarePlanRef-1016">
						<td>01/24/2023</td>
						<td>LABORDER</td>
						<td>CMP</td>
				</tr>
				<tr ID="CarePlanRef-1017">
						<td>01/24/2023</td>
						<td>LABORDER</td>
						<td>CEA panel</td>
				</tr>
				<tr ID="CarePlanRef-1018">
						<td>01/24/2023</td>
						<td>LABORDER</td>
						<td>T3, free panel</td>
				</tr>
				<tr ID="CarePlanRef-1019">
						<td>01/24/2023</td>
						<td>LABORDER</td>
						<td>TSH panel</td>
				</tr>
				<tr ID="CarePlanRef-1020">
						<td>01/24/2023</td>
						<td>LABORDER</td>
						<td>T4, free panel</td>
				</tr>
				<tr ID="CarePlanRef-1021">
						<td>01/24/2023</td>
						<td>LABORDER</td>
						<td>Hemoglobin A1c panel</td>
				</tr>
				<tr ID="CarePlanRef-1022">
						<td>01/24/2023</td>
						<td>LABORDER</td>
						<td>Lipid panel</td>
				</tr>
	</tbody>
</table>
</div><h3><a name="id4" href="#toc">Reason for Visit</a></h3><div>PORT FLUSH 15 MIN</div><h3><a name="id5" href="#toc">Encounters</a></h3><div><table>
	<thead>
		<tr>
							<th>Date</th>
				<th>Name</th>
		</tr>
	</thead>
	<tbody>
					<tr ID="EncounterDiagnosisRef-1023">
							<td>12/20/2022</td>
							<td>Non-small cell lung cancer (disorder)</td>						
					</tr>
	</tbody>
</table>
</div><h3><a name="id6" href="#toc">Immunizations</a></h3><div><table>
	<thead>
		<tr>
							<th>Date</th>
				<th>Name</th>
				<th>Route</th>
				<th>Dose</th>
				<th>Instructions</th>
				<th>Refusal Reason</th>
				<th>Status</th>
		</tr>
	</thead>
	<tbody>
				<tr><td colspan="7">No data for this encounter</td></tr>
	</tbody>
</table>
</div><h3><a name="id7" href="#toc">Diagnostic Results</a></h3><div><table>
	<thead>
		<tr>
							<th>Date</th>
				<th>Type</th>
				<th>Test</th>
				<th>Units</th>
				<th>Lower Limit</th>
				<th>Upper Limit</th>
				<th>Result</th>
				<th>Flag</th>
				<th>Comments</th>
				<th>Status</th>
				<th>Ordered By</th>
				<th>Specimen Source</th>
				<th>Lab Address</th>
		</tr>
	</thead>
	<tbody>
				<tr ID="ResultOBS-1024">
						<td>01/24/2023</td>
						<td>Lipid panel</td>
						<td>Total HDL-cholesterol direct</td>
						<td>mg/dL</td>
						<td>40.0</td>
						<td>100.0</td>
						<td>55</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>SER</td>
                        <td>TWAIN, 3730 S. Eastern Avenue LAS VEGAS NV 891690000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1025">
						<td>01/24/2023</td>
						<td>Lipid panel</td>
						<td>LDL cholesterol, direct</td>
						<td>mg/dL</td>
						<td>5.0</td>
						<td>110.0</td>
						<td>76</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>SER</td>
                        <td>TWAIN, 3730 S. Eastern Avenue LAS VEGAS NV 891690000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1026">
						<td>01/24/2023</td>
						<td>Lipid panel</td>
						<td>Triglycerides</td>
						<td>mg/dL</td>
						<td>0.0</td>
						<td>150.0</td>
						<td>73</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>SER</td>
                        <td>TWAIN, 3730 S. Eastern Avenue LAS VEGAS NV 891690000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1027">
						<td>01/24/2023</td>
						<td>Lipid panel</td>
						<td>Cholesterol</td>
						<td>mg/dL</td>
						<td>1.0</td>
						<td>200.0</td>
						<td>131</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>SER</td>
                        <td>TWAIN, 3730 S. Eastern Avenue LAS VEGAS NV 891690000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1028">
						<td>01/24/2023</td>
						<td>CEA panel</td>
						<td>CEA</td>
						<td>ng/mL</td>
						<td>0.1</td>
						<td>3.0</td>
						<td>0.9</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>SER</td>
                        <td>TWAIN, 3730 S. Eastern Avenue LAS VEGAS NV 891690000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1029">
						<td>01/24/2023</td>
						<td>CA 27-29 panel</td>
						<td>CA 27-29</td>
						<td>U/mL</td>
						<td>0.0</td>
						<td>38.6</td>
						<td>90.5</td>
						<td>High</td>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>SER</td>
                        <td>TWAIN, 3730 S. Eastern Avenue LAS VEGAS NV 891690000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1030">
						<td>01/24/2023</td>
						<td>T4, free panel</td>
						<td>T4, free</td>
						<td>ng/dL</td>
						<td>0.89</td>
						<td>1.76</td>
						<td>1.43</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>SER</td>
                        <td>TWAIN, 3730 S. Eastern Avenue LAS VEGAS NV 891690000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1031">
						<td>01/24/2023</td>
						<td>T3, free panel</td>
						<td>T3, free</td>
						<td>pg/mL</td>
						<td>2.3</td>
						<td>4.2</td>
						<td>2.8</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>SER</td>
                        <td>TWAIN, 3730 S. Eastern Avenue LAS VEGAS NV 891690000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1032">
						<td>01/24/2023</td>
						<td>TSH panel</td>
						<td>TSH</td>
						<td>uIU/mL</td>
						<td>0.5</td>
						<td>4.8</td>
						<td>0.02 Critical Value Verified x 2</td>
						<td>Critical Low</td>
						<td>CRITICAL TSH TO RN</td>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>SER</td>
                        <td>TWAIN, 3730 S. Eastern Avenue LAS VEGAS NV 891690000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1033">
						<td>01/24/2023</td>
						<td>CBC w/ auto diff</td>
						<td>WBC</td>
						<td>K/uL</td>
						<td>5.3</td>
						<td>12.2</td>
						<td>7.3</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>WB</td>
                        <td>SIENA, 10001 S. Eastern Ave., Suite 108 HENDERSON NV 890520000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1034">
						<td>01/24/2023</td>
						<td>CBC w/ auto diff</td>
						<td>RBC</td>
						<td>M/uL</td>
						<td>4.0</td>
						<td>5.5</td>
						<td>4.04</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>WB</td>
                        <td>SIENA, 10001 S. Eastern Ave., Suite 108 HENDERSON NV 890520000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1035">
						<td>01/24/2023</td>
						<td>CBC w/ auto diff</td>
						<td>HGB</td>
						<td>g/dL</td>
						<td>11.0</td>
						<td>15.5</td>
						<td>13.2</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>WB</td>
                        <td>SIENA, 10001 S. Eastern Ave., Suite 108 HENDERSON NV 890520000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1036">
						<td>01/24/2023</td>
						<td>CBC w/ auto diff</td>
						<td>HCT</td>
						<td>%</td>
						<td>33.0</td>
						<td>48.0</td>
						<td>38.7</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>WB</td>
                        <td>SIENA, 10001 S. Eastern Ave., Suite 108 HENDERSON NV 890520000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1037">
						<td>01/24/2023</td>
						<td>CBC w/ auto diff</td>
						<td>MCV</td>
						<td>fL</td>
						<td>77.0</td>
						<td>95.0</td>
						<td>96</td>
						<td>High</td>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>WB</td>
                        <td>SIENA, 10001 S. Eastern Ave., Suite 108 HENDERSON NV 890520000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1038">
						<td>01/24/2023</td>
						<td>CBC w/ auto diff</td>
						<td>MCH</td>
						<td>pg</td>
						<td>26.0</td>
						<td>33.0</td>
						<td>33</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>WB</td>
                        <td>SIENA, 10001 S. Eastern Ave., Suite 108 HENDERSON NV 890520000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1039">
						<td>01/24/2023</td>
						<td>CBC w/ auto diff</td>
						<td>MCHC</td>
						<td>g/dL</td>
						<td>32.0</td>
						<td>36.0</td>
						<td>34.1</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>WB</td>
                        <td>SIENA, 10001 S. Eastern Ave., Suite 108 HENDERSON NV 890520000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1040">
						<td>01/24/2023</td>
						<td>CBC w/ auto diff</td>
						<td>RDW</td>
						<td>%</td>
						<td>10.0</td>
						<td>15.0</td>
						<td>13.3</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>WB</td>
                        <td>SIENA, 10001 S. Eastern Ave., Suite 108 HENDERSON NV 890520000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1041">
						<td>01/24/2023</td>
						<td>CBC w/ auto diff</td>
						<td>PLT</td>
						<td>10e3/uL</td>
						<td>150.0</td>
						<td>450.0</td>
						<td>155</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>WB</td>
                        <td>SIENA, 10001 S. Eastern Ave., Suite 108 HENDERSON NV 890520000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1042">
						<td>01/24/2023</td>
						<td>CBC w/ auto diff</td>
						<td>Neu %</td>
						<td>%</td>
						<td>42.0</td>
						<td>71.0</td>
						<td>41</td>
						<td>Low</td>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>WB</td>
                        <td>SIENA, 10001 S. Eastern Ave., Suite 108 HENDERSON NV 890520000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1043">
						<td>01/24/2023</td>
						<td>CBC w/ auto diff</td>
						<td>LY %</td>
						<td>%</td>
						<td>24.0</td>
						<td>44.0</td>
						<td>50</td>
						<td>High</td>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>WB</td>
                        <td>SIENA, 10001 S. Eastern Ave., Suite 108 HENDERSON NV 890520000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1044">
						<td>01/24/2023</td>
						<td>CBC w/ auto diff</td>
						<td>MO %</td>
						<td>%</td>
						<td>2.0</td>
						<td>12.0</td>
						<td>7</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>WB</td>
                        <td>SIENA, 10001 S. Eastern Ave., Suite 108 HENDERSON NV 890520000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1045">
						<td>01/24/2023</td>
						<td>CBC w/ auto diff</td>
						<td>EO %</td>
						<td>%</td>
						<td>0.0</td>
						<td>8.0</td>
						<td>3</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>WB</td>
                        <td>SIENA, 10001 S. Eastern Ave., Suite 108 HENDERSON NV 890520000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1046">
						<td>01/24/2023</td>
						<td>CBC w/ auto diff</td>
						<td>BA %</td>
						<td>%</td>
						<td>0.0</td>
						<td>3.0</td>
						<td>0</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>WB</td>
                        <td>SIENA, 10001 S. Eastern Ave., Suite 108 HENDERSON NV 890520000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1047">
						<td>01/24/2023</td>
						<td>CBC w/ auto diff</td>
						<td>Neu # (ANC)</td>
						<td>K/uL</td>
						<td>2.4</td>
						<td>5.2</td>
						<td>2.9</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>WB</td>
                        <td>SIENA, 10001 S. Eastern Ave., Suite 108 HENDERSON NV 890520000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1048">
						<td>01/24/2023</td>
						<td>CBC w/ auto diff</td>
						<td>LY #</td>
						<td>K/uL</td>
						<td>1.5</td>
						<td>3.7</td>
						<td>3.6</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>WB</td>
                        <td>SIENA, 10001 S. Eastern Ave., Suite 108 HENDERSON NV 890520000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1049">
						<td>01/24/2023</td>
						<td>CBC w/ auto diff</td>
						<td>MO #</td>
						<td>K/uL</td>
						<td>0.4</td>
						<td>1.2</td>
						<td>0.5</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>WB</td>
                        <td>SIENA, 10001 S. Eastern Ave., Suite 108 HENDERSON NV 890520000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1050">
						<td>01/24/2023</td>
						<td>CBC w/ auto diff</td>
						<td>EO #</td>
						<td>10e3/uL</td>
						<td>0.0</td>
						<td>0.2</td>
						<td>0.20</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>WB</td>
                        <td>SIENA, 10001 S. Eastern Ave., Suite 108 HENDERSON NV 890520000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1051">
						<td>01/24/2023</td>
						<td>CBC w/ auto diff</td>
						<td>BA #</td>
						<td>K/uL</td>
						<td>0.0</td>
						<td>0.1</td>
						<td>0.0</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>WB</td>
                        <td>SIENA, 10001 S. Eastern Ave., Suite 108 HENDERSON NV 890520000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1052">
						<td>01/24/2023</td>
						<td>Hemoglobin A1c panel</td>
						<td>Hgb A1c</td>
						<td>%</td>
						<td>0.0</td>
						<td>5.7</td>
						<td>4.9</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>WB</td>
                        <td>TWAIN, 3730 S. Eastern Avenue LAS VEGAS NV 891690000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1053">
						<td>01/24/2023</td>
						<td>CMP</td>
						<td>Glucose</td>
						<td>mg/dL</td>
						<td>74.0</td>
						<td>106.0</td>
						<td>94</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>SER</td>
                        <td>TWAIN, 3730 S. Eastern Avenue LAS VEGAS NV 891690000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1054">
						<td>01/24/2023</td>
						<td>CMP</td>
						<td>BUN</td>
						<td>mg/dL</td>
						<td>9.0</td>
						<td>23.0</td>
						<td>25</td>
						<td>High</td>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>SER</td>
                        <td>TWAIN, 3730 S. Eastern Avenue LAS VEGAS NV 891690000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1055">
						<td>01/24/2023</td>
						<td>CMP</td>
						<td>Creatinine</td>
						<td>mg/dL</td>
						<td>0.6</td>
						<td>1.3</td>
						<td>1.1</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>SER</td>
                        <td>TWAIN, 3730 S. Eastern Avenue LAS VEGAS NV 891690000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1056">
						<td>01/24/2023</td>
						<td>CMP</td>
						<td>Calcium</td>
						<td>mg/dL</td>
						<td>8.7</td>
						<td>10.4</td>
						<td>8.7</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>SER</td>
                        <td>TWAIN, 3730 S. Eastern Avenue LAS VEGAS NV 891690000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1057">
						<td>01/24/2023</td>
						<td>CMP</td>
						<td>Total protein</td>
						<td>g/dL</td>
						<td>5.7</td>
						<td>8.2</td>
						<td>7.2</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>SER</td>
                        <td>TWAIN, 3730 S. Eastern Avenue LAS VEGAS NV 891690000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1058">
						<td>01/24/2023</td>
						<td>CMP</td>
						<td>Alkaline phosphatase</td>
						<td>U/L</td>
						<td>45.0</td>
						<td>129.0</td>
						<td>71</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>SER</td>
                        <td>TWAIN, 3730 S. Eastern Avenue LAS VEGAS NV 891690000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1059">
						<td>01/24/2023</td>
						<td>CMP</td>
						<td>ALT/SGPT</td>
						<td>U/L</td>
						<td>10.0</td>
						<td>49.0</td>
						<td>47</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>SER</td>
                        <td>TWAIN, 3730 S. Eastern Avenue LAS VEGAS NV 891690000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1060">
						<td>01/24/2023</td>
						<td>CMP</td>
						<td>AST/SGOT</td>
						<td>U/L</td>
						<td>3.0</td>
						<td>34.0</td>
						<td>42</td>
						<td>High</td>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>SER</td>
                        <td>TWAIN, 3730 S. Eastern Avenue LAS VEGAS NV 891690000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1061">
						<td>01/24/2023</td>
						<td>CMP</td>
						<td>Sodium, mEq/L</td>
						<td>meq/L</td>
						<td>136.0</td>
						<td>145.0</td>
						<td>137</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>SER</td>
                        <td>TWAIN, 3730 S. Eastern Avenue LAS VEGAS NV 891690000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1062">
						<td>01/24/2023</td>
						<td>CMP</td>
						<td>Potassium</td>
						<td>mmol/L</td>
						<td>3.4</td>
						<td>5.1</td>
						<td>4.0</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>SER</td>
                        <td>TWAIN, 3730 S. Eastern Avenue LAS VEGAS NV 891690000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1063">
						<td>01/24/2023</td>
						<td>CMP</td>
						<td>Chloride, mEq/L</td>
						<td>meq/L</td>
						<td>98.0</td>
						<td>107.0</td>
						<td>104</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>SER</td>
                        <td>TWAIN, 3730 S. Eastern Avenue LAS VEGAS NV 891690000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1064">
						<td>01/24/2023</td>
						<td>CMP</td>
						<td>CO2 content</td>
						<td>meq/L</td>
						<td>20.0</td>
						<td>31.0</td>
						<td>29</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>SER</td>
                        <td>TWAIN, 3730 S. Eastern Avenue LAS VEGAS NV 891690000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1065">
						<td>01/24/2023</td>
						<td>CMP</td>
						<td>GFR estimate</td>
						<td>ml/min/1.73m2</td>
						<td/>
						<td/>
						<td>50</td>
						<td>Low</td>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>SER</td>
                        <td>TWAIN, 3730 S. Eastern Avenue LAS VEGAS NV 891690000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1066">
						<td>01/24/2023</td>
						<td>CMP</td>
						<td>GFR African American, estimated</td>
						<td>ml/min/1.73m2</td>
						<td/>
						<td/>
						<td>61</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>SER</td>
                        <td>TWAIN, 3730 S. Eastern Avenue LAS VEGAS NV 891690000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1067">
						<td>01/24/2023</td>
						<td>CMP</td>
						<td>Albumin</td>
						<td>g/dL</td>
						<td>3.2</td>
						<td>4.8</td>
						<td>3.7</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>SER</td>
                        <td>TWAIN, 3730 S. Eastern Avenue LAS VEGAS NV 891690000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1068">
						<td>01/24/2023</td>
						<td>CMP</td>
						<td>Bilirubin, total</td>
						<td>mg/dL</td>
						<td>0.3</td>
						<td>1.2</td>
						<td>1.0</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>SER</td>
                        <td>TWAIN, 3730 S. Eastern Avenue LAS VEGAS NV 891690000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1069">
						<td>01/24/2023</td>
						<td>CMP</td>
						<td>A/G ratio</td>
						<td>%</td>
						<td>0.9</td>
						<td>1.9</td>
						<td>1.1</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>SER</td>
                        <td>TWAIN, 3730 S. Eastern Avenue LAS VEGAS NV 891690000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1070">
						<td>01/24/2023</td>
						<td>CMP</td>
						<td>Globulin</td>
						<td>g/dL</td>
						<td>2.5</td>
						<td>3.4</td>
						<td>3.50</td>
						<td>High</td>
						<td/>
						<td>FINAL</td>
						<td>Rupesh Parikh</td>
                        <td>SER</td>
                        <td>TWAIN, 3730 S. Eastern Avenue LAS VEGAS NV 891690000  Edwin Kingsley </td>
				</tr>
	</tbody>
</table>
</div><h3><a name="id8" href="#toc">Medications</a></h3><div><table>
	<thead>
		<tr>
							<th>Date</th>
				<th>Name</th>
				<th>Route</th>
				<th>Dose</th>
				<th>Frequency</th>
				<th>Instructions</th>
				<th>Start Date</th>
				<th>End Date</th>
				<th>Status</th>
		</tr>
	</thead>
	<tbody>
					<tr ID="MedicationOBS-1071">
							<td/>
							<td>Cholecalciferol Oral </td>
							<td>orally</td>
							<td>5000.0 unit</td>
							<td>daily</td>
							<td/>
							<td/>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1072">
							<td/>
							<td>Apixaban Oral </td>
							<td>orally</td>
							<td>5.0 mg</td>
							<td>2 times per day</td>
							<td/>
							<td/>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1073">
							<td/>
							<td>Furosemide Oral </td>
							<td>po</td>
							<td>1.0 tablet</td>
							<td>PRN</td>
							<td/>
							<td/>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1074">
							<td/>
							<td>Potassium Chloride Oral ER Tab </td>
							<td>po</td>
							<td>1.0 tablet extended release</td>
							<td>PRN</td>
							<td/>
							<td/>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1075">
							<td>01/07/2025</td>
							<td>Epinephrine IM </td>
							<td>intramuscularly</td>
							<td>0.3 mg</td>
							<td>PRN anaphylaxis or severe hypersensitivity reaction</td>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>01/07/2025</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1076">
							<td>01/07/2025</td>
							<td>Hydrocortisone IV </td>
							<td>intravenous</td>
							<td>100.0 mg</td>
							<td>Use as Directed</td>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>01/07/2025</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1077">
							<td>01/07/2025</td>
							<td>Methylprednisolone IV </td>
							<td>intravenous</td>
							<td>125.0 mg</td>
							<td>Use as Directed</td>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>01/07/2025</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1078">
							<td>01/07/2025</td>
							<td>Famotidine IV </td>
							<td>intravenous</td>
							<td>20.0 mg</td>
							<td>Use as Directed</td>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>01/07/2025</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1079">
							<td>01/07/2025</td>
							<td>Denosumab Subcutaneous (60 mg/mL - Prolia) </td>
							<td>subcutaneously</td>
							<td>60.0 mg</td>
							<td/>
							<td>Administer SQ injection in the upper arm, upper thigh or abdomen.</td>
							<td>01/07/2025</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1080">
							<td>01/07/2025</td>
							<td>Diphenhydramine IV </td>
							<td>intravenous</td>
							<td>50.0 mg</td>
							<td>Use as Directed</td>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>01/07/2025</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1081">
							<td>07/09/2024</td>
							<td>Epinephrine IM </td>
							<td>intramuscularly</td>
							<td>0.3 mg</td>
							<td>PRN anaphylaxis or severe hypersensitivity reaction</td>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>07/09/2024</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1082">
							<td>07/09/2024</td>
							<td>Hydrocortisone IV </td>
							<td>intravenous</td>
							<td>100.0 mg</td>
							<td>Use as Directed</td>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>07/09/2024</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1083">
							<td>07/09/2024</td>
							<td>Diphenhydramine IV </td>
							<td>intravenous</td>
							<td>50.0 mg</td>
							<td>Use as Directed</td>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>07/09/2024</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1084">
							<td>07/09/2024</td>
							<td>Methylprednisolone IV </td>
							<td>intravenous</td>
							<td>125.0 mg</td>
							<td>Use as Directed</td>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>07/09/2024</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1085">
							<td>07/09/2024</td>
							<td>Famotidine IV </td>
							<td>intravenous</td>
							<td>20.0 mg</td>
							<td>Use as Directed</td>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>07/09/2024</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1086">
							<td>07/09/2024</td>
							<td>Denosumab Subcutaneous (60 mg/mL - Prolia) </td>
							<td>subcutaneously</td>
							<td>60.0 mg</td>
							<td/>
							<td>Administer SQ injection in the upper arm, upper thigh or abdomen.</td>
							<td>07/09/2024</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1087">
							<td>06/28/2024</td>
							<td>exemestane 25 MG Oral Tablet [Aromasin] </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td>daily</td>
							<td/>
							<td>06/28/2024</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1088">
							<td>06/28/2024</td>
							<td>24 HR venlafaxine 75 MG Extended Release Oral Capsule </td>
							<td>orally</td>
							<td>1.0 capsule,extended release 24hr</td>
							<td>daily</td>
							<td/>
							<td>06/28/2024</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1089">
							<td>06/28/2024</td>
							<td>levothyroxine sodium 0.1 MG Oral Tablet </td>
							<td>orally</td>
							<td>1.0 tablet</td>
							<td>every day</td>
							<td/>
							<td>06/28/2024</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1090">
							<td>04/04/2024</td>
							<td>calcitriol 0.00025 MG Oral Capsule </td>
							<td>orally</td>
							<td>1.0 capsule(s)</td>
							<td>daily</td>
							<td/>
							<td>04/04/2024</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1091">
							<td>04/04/2024</td>
							<td>folic acid 1 MG Oral Tablet </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td>daily</td>
							<td/>
							<td>04/04/2024</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1092">
							<td>01/09/2024</td>
							<td>Epinephrine IM </td>
							<td>intramuscularly</td>
							<td>0.3 mg</td>
							<td>PRN anaphylaxis or severe hypersensitivity reaction</td>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>01/09/2024</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1093">
							<td>01/09/2024</td>
							<td>Diphenhydramine IV </td>
							<td>intravenous</td>
							<td>50.0 mg</td>
							<td>Use as Directed</td>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>01/09/2024</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1094">
							<td>01/09/2024</td>
							<td>Methylprednisolone IV </td>
							<td>intravenous</td>
							<td>125.0 mg</td>
							<td>Use as Directed</td>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>01/09/2024</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1095">
							<td>01/09/2024</td>
							<td>Famotidine IV </td>
							<td>intravenous</td>
							<td>20.0 mg</td>
							<td>Use as Directed</td>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>01/09/2024</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1096">
							<td>01/09/2024</td>
							<td>Hydrocortisone IV </td>
							<td>intravenous</td>
							<td>100.0 mg</td>
							<td>Use as Directed</td>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>01/09/2024</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1097">
							<td>01/03/2024</td>
							<td>donepezil hydrochloride 10 MG Oral Tablet [Aricept] </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td>daily</td>
							<td/>
							<td>01/03/2024</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1098">
							<td>12/20/2023</td>
							<td>osimertinib 80 MG Oral Tablet [Tagrisso] </td>
							<td>orally</td>
							<td>1.0 tablet</td>
							<td>daily</td>
							<td/>
							<td>12/20/2023</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1099">
							<td>12/11/2023</td>
							<td>osimertinib 80 MG Oral Tablet [Tagrisso] </td>
							<td>orally</td>
							<td>1.0 tablet</td>
							<td>daily</td>
							<td/>
							<td>12/11/2023</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1100">
							<td>08/02/2023</td>
							<td>osimertinib 80 MG Oral Tablet [Tagrisso] </td>
							<td>orally</td>
							<td>1.0 tablet</td>
							<td>daily</td>
							<td/>
							<td>08/02/2023</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1101">
							<td>06/28/2023</td>
							<td>24 HR venlafaxine 75 MG Extended Release Oral Capsule </td>
							<td>orally</td>
							<td>1.0 capsule,extended release 24hr</td>
							<td>daily</td>
							<td/>
							<td>06/28/2023</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1102">
							<td>06/26/2023</td>
							<td>Hydrocortisone IV </td>
							<td>intravenous</td>
							<td>100.0 mg</td>
							<td>Use as Directed</td>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>06/26/2023</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1103">
							<td>06/26/2023</td>
							<td>Epinephrine IM </td>
							<td>intramuscularly</td>
							<td>0.3 mg</td>
							<td>PRN anaphylaxis or severe hypersensitivity reaction</td>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>06/26/2023</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1104">
							<td>06/26/2023</td>
							<td>Diphenhydramine IV </td>
							<td>intravenous</td>
							<td>50.0 mg</td>
							<td>Use as Directed</td>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>06/26/2023</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1105">
							<td>06/26/2023</td>
							<td>Famotidine IV </td>
							<td>intravenous</td>
							<td>20.0 mg</td>
							<td>Use as Directed</td>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>06/26/2023</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1106">
							<td>06/26/2023</td>
							<td>Methylprednisolone IV </td>
							<td>intravenous</td>
							<td>125.0 mg</td>
							<td>Use as Directed</td>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>06/26/2023</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1107">
							<td>06/23/2023</td>
							<td>exemestane 25 MG Oral Tablet [Aromasin] </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td>daily</td>
							<td/>
							<td>06/23/2023</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1108">
							<td>04/10/2023</td>
							<td>calcitriol 0.00025 MG Oral Capsule </td>
							<td>orally</td>
							<td>1.0 capsule(s)</td>
							<td>daily</td>
							<td/>
							<td>04/10/2023</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1109">
							<td>04/10/2023</td>
							<td>folic acid 1 MG Oral Tablet </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td>daily</td>
							<td/>
							<td>04/10/2023</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1110">
							<td>01/27/2023</td>
							<td>donepezil hydrochloride 10 MG Oral Tablet [Aricept] </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td>daily</td>
							<td/>
							<td>01/27/2023</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1111">
							<td>12/29/2022</td>
							<td>osimertinib 80 MG Oral Tablet [Tagrisso] </td>
							<td>orally</td>
							<td>1.0 tablet</td>
							<td>daily</td>
							<td/>
							<td>12/29/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1112">
							<td>12/20/2022</td>
							<td>Famotidine IV </td>
							<td>intravenous</td>
							<td>20.0 mg</td>
							<td>Use as Directed</td>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>12/20/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1113">
							<td>12/20/2022</td>
							<td>Hydrocortisone IV </td>
							<td>intravenous</td>
							<td>100.0 mg</td>
							<td>Use as Directed</td>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>12/20/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1114">
							<td>12/20/2022</td>
							<td>Diphenhydramine IV </td>
							<td>intravenous</td>
							<td>50.0 mg</td>
							<td>Use as Directed</td>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>12/20/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1115">
							<td>12/20/2022</td>
							<td>Epinephrine IM </td>
							<td>intramuscularly</td>
							<td>0.3 mg</td>
							<td>PRN anaphylaxis or severe hypersensitivity reaction</td>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>12/20/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1116">
							<td>12/20/2022</td>
							<td>Methylprednisolone IV </td>
							<td>intravenous</td>
							<td>125.0 mg</td>
							<td>Use as Directed</td>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>12/20/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1117">
							<td>11/08/2022</td>
							<td>calcitriol 0.00025 MG Oral Capsule </td>
							<td>orally</td>
							<td>1.0 capsule(s)</td>
							<td>daily</td>
							<td/>
							<td>11/08/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1118">
							<td>11/04/2022</td>
							<td>calcitriol 0.00025 MG Oral Capsule </td>
							<td>orally</td>
							<td>1.0 capsule(s)</td>
							<td>3 times per week</td>
							<td/>
							<td>11/04/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1119">
							<td>08/10/2022</td>
							<td>exemestane 25 MG Oral Tablet [Aromasin] </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td>daily</td>
							<td/>
							<td>08/10/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1120">
							<td>07/13/2022</td>
							<td>osimertinib 80 MG Oral Tablet [Tagrisso] </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>07/13/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1121">
							<td>07/13/2022</td>
							<td>Multivitamins Oral Tablet </td>
							<td>PO</td>
							<td>1.0 TABLET(S)</td>
							<td>daily</td>
							<td/>
							<td>07/13/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1122">
							<td>07/13/2022</td>
							<td>Atorvastatin Oral </td>
							<td>PO</td>
							<td>1.0 TABLET(S)</td>
							<td>daily</td>
							<td/>
							<td>07/13/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1123">
							<td>07/13/2022</td>
							<td>Magnesium Oxide Oral </td>
							<td>PO</td>
							<td>400.0 MG</td>
							<td>daily</td>
							<td/>
							<td>07/13/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1124">
							<td>07/13/2022</td>
							<td>Metoprolol Oral 24 hr Tab (Succinate) </td>
							<td>PO</td>
							<td>1.0 TABLET(S), SUSTAINED RELEASE 24HR</td>
							<td>daily</td>
							<td/>
							<td>07/13/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1125">
							<td>07/13/2022</td>
							<td>Biotin Oral </td>
							<td>PO</td>
							<td>1.0 CAPSULE(S)</td>
							<td>daily</td>
							<td/>
							<td>07/13/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1126">
							<td>07/13/2022</td>
							<td>Midodrine Oral </td>
							<td>PO</td>
							<td>1.0 TABLET(S)</td>
							<td>TID</td>
							<td>AS DIRECTED</td>
							<td>07/13/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1127">
							<td>07/13/2022</td>
							<td>Coenzyme Q10 Oral </td>
							<td>PO</td>
							<td>1.0 CAPSULE(S)</td>
							<td>daily</td>
							<td>300 mg</td>
							<td>07/13/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1128">
							<td>07/13/2022</td>
							<td>Omega 3 Fatty Acids-Fish Oil Oral 300 mg-1,000 mg </td>
							<td>PO</td>
							<td>1.0 CAPSULE(S)</td>
							<td>daily</td>
							<td>1400 mg gel tab</td>
							<td>07/13/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1129">
							<td>07/06/2022</td>
							<td>osimertinib 80 MG Oral Tablet [Tagrisso] </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>07/06/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1130">
							<td>07/06/2022</td>
							<td>osimertinib 80 MG Oral Tablet [Tagrisso] </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>07/06/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1131">
							<td>06/15/2022</td>
							<td>hydrocortisone 100 MG Injection </td>
							<td>intravenous</td>
							<td>100.0 mg</td>
							<td>Use as Directed</td>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>06/15/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1132">
							<td>06/15/2022</td>
							<td>methylprednisolone 125 MG Injection </td>
							<td>intravenous</td>
							<td>125.0 mg</td>
							<td>Use as Directed</td>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>06/15/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1133">
							<td>06/15/2022</td>
							<td>famotidine 10 MG/ML Injectable Solution </td>
							<td>intravenous</td>
							<td>20.0 mg</td>
							<td>Use as Directed</td>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>06/15/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1134">
							<td>06/15/2022</td>
							<td>diphenhydramine hydrochloride 50 MG/ML Injectable Solution </td>
							<td>intravenous</td>
							<td>50.0 mg</td>
							<td>Use as Directed</td>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>06/15/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1135">
							<td>06/15/2022</td>
							<td>epinephrine 1 MG/ML Injectable Solution </td>
							<td>intramuscularly</td>
							<td>0.3 mg</td>
							<td/>
							<td>Re-initiate treatment only upon physician approval.</td>
							<td>06/15/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1136">
							<td>06/03/2022</td>
							<td>donepezil hydrochloride 10 MG Oral Tablet [Aricept] </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>06/03/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1137">
							<td>06/03/2022</td>
							<td>folic acid 1 MG Oral Tablet </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>06/03/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1138">
							<td>06/03/2022</td>
							<td>calcitriol 0.00025 MG Oral Capsule </td>
							<td>orally</td>
							<td>1.0 capsule(s)</td>
							<td/>
							<td/>
							<td>06/03/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1139">
							<td>05/12/2022</td>
							<td>osimertinib 80 MG Oral Tablet [Tagrisso] </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>05/12/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1140">
							<td>01/13/2022</td>
							<td>calcitriol 0.00025 MG Oral Capsule </td>
							<td>orally</td>
							<td>1.0 capsule(s)</td>
							<td/>
							<td/>
							<td>01/13/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1141">
							<td>12/09/2021</td>
							<td>sodium chloride 1000 MG Oral Tablet </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td>2 times per day</td>
							<td/>
							<td>12/09/2021</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1142">
							<td>12/09/2021</td>
							<td>osimertinib 80 MG Oral Tablet [Tagrisso] </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>12/09/2021</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1143">
							<td>12/09/2021</td>
							<td>Calcium Carbonate Oral Chewable </td>
							<td>PO</td>
							<td>1.0 (1,000 mg)</td>
							<td>TID</td>
							<td/>
							<td>12/09/2021</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1144">
							<td>09/22/2021</td>
							<td>donepezil hydrochloride 10 MG Oral Tablet [Aricept] </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>09/22/2021</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1145">
							<td>07/19/2021</td>
							<td>folic acid 1 MG Oral Tablet </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>07/19/2021</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1146">
							<td>07/19/2021</td>
							<td>exemestane 25 MG Oral Tablet [Aromasin] </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>07/19/2021</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1147">
							<td>06/24/2021</td>
							<td>osimertinib 80 MG Oral Tablet [Tagrisso] </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>06/24/2021</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1148">
							<td>06/24/2021</td>
							<td>donepezil hydrochloride 10 MG Oral Tablet [Aricept] </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>06/24/2021</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1149">
							<td>05/28/2021</td>
							<td>osimertinib 80 MG Oral Tablet [Tagrisso] </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>05/28/2021</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1150">
							<td>04/22/2021</td>
							<td>osimertinib 80 MG Oral Tablet [Tagrisso] </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>04/22/2021</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1151">
							<td>03/24/2021</td>
							<td>osimertinib 80 MG Oral Tablet [Tagrisso] </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>03/24/2021</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1152">
							<td>11/05/2020</td>
							<td>exemestane 25 MG Oral Tablet [Aromasin] </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>11/05/2020</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1153">
							<td>09/02/2020</td>
							<td>exemestane 25 MG Oral Tablet [Aromasin] </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>09/02/2020</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1154">
							<td>09/02/2020</td>
							<td>exemestane 25 MG Oral Tablet [Aromasin] </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>09/02/2020</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1155">
							<td>08/05/2020</td>
							<td>folic acid 1 MG Oral Tablet </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>08/05/2020</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1156">
							<td>06/10/2020</td>
							<td>osimertinib 80 MG Oral Tablet [Tagrisso] </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>06/10/2020</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1157">
							<td>10/29/2019</td>
							<td>folic acid 1 MG Oral Tablet </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>10/29/2019</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1158">
							<td>10/29/2019</td>
							<td>folic acid 1 MG Oral Tablet </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>10/29/2019</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1159">
							<td>03/06/2019</td>
							<td>vitamin B12 1 MG/ML Injectable Solution </td>
							<td>intramuscularly</td>
							<td>1000.0 mcg</td>
							<td>As Directed</td>
							<td>NOTE: C4D1 - Select appropriate order date. Vitamin B-12 1000 mcg IM is given beginning 7 days prior to pemetrexed and repeated every 9 weeks (3 cycles) until 3 weeks past final pemetrexed dose.</td>
							<td>03/06/2019</td>
							<td>03/06/2019</td>
							<td>on hold</td>
					</tr>
					<tr ID="MedicationOBS-1160">
							<td>03/06/2019</td>
							<td>folic acid 1 MG Oral Tablet </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>03/06/2019</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1161">
							<td>02/13/2019</td>
							<td>folic acid 1 MG Oral Tablet </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>02/13/2019</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1162">
							<td>02/12/2019</td>
							<td>folic acid 1 MG Oral Tablet </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>02/12/2019</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1163">
							<td>01/23/2019</td>
							<td>folic acid 1 MG Oral Tablet </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>01/23/2019</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1164">
							<td>01/04/2019</td>
							<td>folic acid 1 MG Oral Tablet </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>01/04/2019</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1165">
							<td>12/31/2018</td>
							<td>folic acid 1 MG Oral Tablet </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>12/31/2018</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1166">
							<td>10/19/2018</td>
							<td>Miscellaneous Drug </td>
							<td>PO</td>
							<td>1.0 CAPSULE(S)</td>
							<td>daily</td>
							<td>500mg 1 PO daily</td>
							<td>10/19/2018</td>
							<td/>
							<td>active</td>
					</tr>
	</tbody>
</table>
</div><h3><a name="id9" href="#toc">Problems</a></h3><div><table>
	<thead>
		<tr>
							<th>Diagnosis</th>
				<th>Status</th>
				<th>Date of Diagnosis</th>
		</tr>
	</thead>
	<tbody>
				<tr ID="ProblemOBS-1167">
						<td>Long-term current use of anticoagulant (situation)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1168">
						<td>Tremor (finding)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1169">
						<td>Non-small cell lung cancer (disorder)</td>
						<td>Active</td>
						<td>12/2018</td>
				</tr>
				<tr ID="ProblemOBS-1170">
						<td>Primary malignant neoplasm of thyroid gland (disorder)</td>
						<td>Active</td>
						<td>2010</td>
				</tr>
				<tr ID="ProblemOBS-1171">
						<td>Fatigue (finding)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1172">
						<td>Orthostatic hypotension (disorder)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1173">
						<td>Hyponatremia (disorder)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1174">
						<td>Depressive disorder (disorder)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1175">
						<td>Gastroesophageal reflux disease (disorder)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1176">
						<td>Abdominal aortic aneurysm (disorder)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1177">
						<td>Primary malignant neoplasm of female breast (disorder)</td>
						<td>Active</td>
						<td>11/08/2018</td>
				</tr>
				<tr ID="ProblemOBS-1178">
						<td>Anxiety (finding)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1179">
						<td>Osteoporosis (disorder)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1180">
						<td>Cancer antigen 27-29 above reference range (finding)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1181">
						<td>Vitamin D deficiency (disorder)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1182">
						<td>Essential hypertension (disorder)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1183">
						<td>Secondary malignant neoplasm of lung (disorder)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1184">
						<td>Atrial arrhythmia (disorder)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1185">
						<td>Hypothyroidism (disorder)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1186">
						<td>Chronic kidney disease (disorder)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1187">
						<td>Hyperlipidemia (disorder)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1188">
						<td>Estrogen receptor positive status [ER+]</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1189">
						<td>Hyperglycemia (disorder)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1190">
						<td>Estrogen receptor negative status [ER-]</td>
						<td>Active</td>
						<td>09/09/2022</td>
				</tr>
				<tr ID="ProblemOBS-1191">
						<td>Estrogen receptor positive status [ER+] </td>
						<td>Active</td>
						<td>09/09/2022</td>
				</tr>
	</tbody>
</table>
</div><h3><a name="id10" href="#toc">Vital Signs</a></h3><div><table>
	<thead>
		<tr>
							<th>Date</th>
				<th>Type</th>
				<th>Value</th>
		</tr>
	</thead>
	<tbody>
				<tr ID="VitalSignsRef-1192">
						<td>12/20/2022</td>
						<td>
							BMI
							
						</td>
						<td>25.20</td>
				</tr>
				<tr ID="VitalSignsRef-1193">
						<td>12/20/2022</td>
						<td>
							Height
							
						</td>
						<td>64.00</td>
				</tr>
				<tr ID="VitalSignsRef-1194">
						<td>12/20/2022</td>
						<td>
							Weight
							
						</td>
						<td>146.80</td>
				</tr>
				<tr ID="VitalSignsRef-1195">
						<td>12/20/2022</td>
						<td>
							Pain Scale
							
						</td>
						<td>0.00</td>
				</tr>
				<tr ID="VitalSignsRef-1196">
						<td>12/20/2022</td>
						<td>
							BSA
							
						</td>
						<td>1.72</td>
				</tr>
				<tr ID="VitalSignsRef-1197">
						<td>12/20/2022</td>
						<td>
							Oxygen Saturation
							
						</td>
						<td>95.00</td>
				</tr>
				<tr ID="VitalSignsRef-1198">
						<td>12/20/2022</td>
						<td>
							Respiratory Rate
							
						</td>
						<td>16.00</td>
				</tr>
				<tr ID="VitalSignsRef-1199">
						<td>12/20/2022</td>
						<td>
							Heart Beat
							
						</td>
						<td>80.00</td>
				</tr>
				<tr ID="VitalSignsRef-1200">
						<td>12/20/2022</td>
						<td>
							Body Temperature
							
						</td>
						<td>98.20</td>
				</tr>
				<tr ID="VitalSignsRef-1201">
						<td>12/20/2022</td>
						<td>
							Intravascular Systolic
							
						</td>
						<td>104</td>
				</tr>
				<tr ID="VitalSignsRef-1202">
						<td>12/20/2022</td>
						<td>
							Intravascular Diastolic
							
						</td>
						<td>70</td>
				</tr>
				<tr ID="VitalSignsRef-1203">
						<td>01/24/2023</td>
						<td>
							Pain Scale
							
						</td>
						<td>0.00</td>
				</tr>
				<tr ID="VitalSignsRef-1204">
						<td>01/24/2023</td>
						<td>
							BMI
							
						</td>
						<td>25.47</td>
				</tr>
				<tr ID="VitalSignsRef-1205">
						<td>01/24/2023</td>
						<td>
							Height
							
						</td>
						<td>64.00</td>
				</tr>
				<tr ID="VitalSignsRef-1206">
						<td>01/24/2023</td>
						<td>
							Weight
							
						</td>
						<td>148.40</td>
				</tr>
				<tr ID="VitalSignsRef-1207">
						<td>01/24/2023</td>
						<td>
							Pain Scale
							
						</td>
						<td>0.00</td>
				</tr>
				<tr ID="VitalSignsRef-1208">
						<td>01/24/2023</td>
						<td>
							BSA
							
						</td>
						<td>1.72</td>
				</tr>
				<tr ID="VitalSignsRef-1209">
						<td>01/24/2023</td>
						<td>
							Oxygen Saturation
							
						</td>
						<td>97.00</td>
				</tr>
				<tr ID="VitalSignsRef-1210">
						<td>01/24/2023</td>
						<td>
							Respiratory Rate
							
						</td>
						<td>16.00</td>
				</tr>
				<tr ID="VitalSignsRef-1211">
						<td>01/24/2023</td>
						<td>
							Heart Beat
							
						</td>
						<td>80.00</td>
				</tr>
				<tr ID="VitalSignsRef-1212">
						<td>01/24/2023</td>
						<td>
							Body Temperature
							
						</td>
						<td>95.80</td>
				</tr>
				<tr ID="VitalSignsRef-1213">
						<td>01/24/2023</td>
						<td>
							Intravascular Systolic
							
						</td>
						<td>118</td>
				</tr>
				<tr ID="VitalSignsRef-1214">
						<td>01/24/2023</td>
						<td>
							Intravascular Diastolic
							
						</td>
						<td>81</td>
				</tr>
	</tbody>
</table>
</div><h3><a name="id11" href="#toc">Notes Section</a></h3><div>	<ul><li>
		        Follow Up Note - Parikh: 
		        <p>
		        		
<br/>
10001 S. Eastern Avenue<br/>
Suite 108<br/>
Henderson, NV 89052<br/>
P: 702-952-3444  F: 702-952-3494<br/>
<br/>

<br/>
PATIENT: SANDIMARI ROHDA

<br/>MRN: 1524290

<br/>DATE: 12/20/2022

<br/>DOB: 10/16/1939

<br/>ATTENDING PHYSICIAN: Rupesh J. Parikh, MD

<br/>
Follow Up Note<br/>
<br/>
<br/>Present Status:<br/>
SANDIMARI ROHDA comes into the clinic today for follow-up, evaluation, and management of Non-small cell lung cancer (disorder) ( Stage Date: 12/20/2018, Stage IVB (Contiguous, overlapping or other specified sites of lung or bronchus, T(Unknown), N1, M1b)-Clinical<br/>
Date of Dx:12/2018 Histopathologic Type: Adenocarcinoma; Histologic Grade: G2; EGFR Expression: Negative; ALK (FISH): Negative; PD-L1: Negative; ROS1 Gene: Unknown; BRAF Mutation: Wild-type; TRK gene: Unknown; First record:12/20/2018 Last record:07/13/2022 Other Migrated ICD10: C34.31 , C34.80 , C34.90 , C34.92 )<br/>
<br/>
Since our last visit, she has been feeling well. <br/>
<br/>
Denies any Tylenol or EOTH consumption. <br/>
<br/>
Port is now in place. <br/>
<br/>
Labs were reviewed and patient made aware counts are stable. WBC count is 7.5 and HGB level is 12.8. <br/>
<br/>
LFTS were reviewed and patient made aware they are elevated. AST level is 105 and ALT level is 99.<br/>
<br/>
Treatment with Prolia to be done today. <br/>
<br/>
Agreeable to get surveillance US liver done prior to return, a referral was sent. <br/>
<br/>
Advised to reduce atorvastatin dosage to every other day. <br/>
<br/>
RTC in 6 weeks with labs to be done prior. <br/>
<br/>
<br/>Review of Systems:<br/>
No nausea, vomiting, headaches, blurry vision or dizziness.  No dysuria or hematuria. No night sweats, fevers or chills. No weight loss.  No cough, sputum or hemoptysis. No bleeding or bruising.<br/>
<br/>
All other systems of 12 reviewed are negative unless otherwise stated. <br/>
<br/>
<br/>Vitals:<br/>
Blood pressure: 104/70, L arm, Regular, Pulse: 80, Temperature: 98.2 F, Respirations: 16, O2 sat: 95%, At Rest, Room Air, Pain Scale: 0, Height: 64 in, Weight: 146.8 lb, BSA: 1.72, BMI: 25.2 kg/m2<br/>
<br/>
<br/>Physical Examination:<br/>
<br/>
GENERAL: Awake, alert, and oriented x 3.<br/>
HEENT: Sclerae are anicteric. Pupils are reactive. Mouth is without lesions.<br/>
NECK: Supple. No cervical lymphadenopathy.<br/>
LUNGS: Clear bilaterally.  No wheezing, rales or rhonchi.<br/>
CVS: S1, S2. No additional sounds.<br/>
EXTREMITIES: No edema, cyanosis or calf tenderness.<br/>
SKIN: No petechiae, rashes, or bruises.<br/>
NEUROLOGIC: Strength is equal and bilateral.<br/>
PSYCHIATRIC: Mood is intact.<br/>
<br/>
<br/>*Laboratory:<br/>
(12/13/2022) WBC x 10^3/uL : 7.5; RBC x 10^6/uL : 3.94 (L); HGB g/dL : 12.8; HCT % : 38.3; MCV fL : 97 (H); MCH pg : 33; MCHC g/dL : 33.4; RDW % : 13.7; PLT x 10^3/uL : 160; Neu % : 43; LY % : 45 (H); MO % : 9; EO % : 4; Neu # (ANC) x 10^3/uL : 3.2; BA % : 0; MO # x 10^3/uL : 0.6; EO # x 10^3/uL : 0.28 (H); BA # x 10^3/uL : 0.0; LY # x 10^3/uL : 3.3<br/>
<br/>
(12/13/2022) Glucose mg/dL : 91; BUN mg/dL : 25 (H); Creatinine mg/dL : 0.9; Potassium mmol/L : 4.4; Sodium, mEq/L : 139; Calcium mg/dL : 9.3; Chloride, mEq/L : 105; Albumin g/dL : 3.8; Total protein g/dL : 7.3; Globulin g/dL : 3.50 (H); A/G ratio : 1.1; Bilirubin, total mg/dL : 0.6; Alkaline phosphatase U/L : 76; AST/SGOT U/L : 105 (H); ALT/SGPT U/L : 99 (H); LDH U/L : 291 (H); GFR estimate mL/min/1.73m2 : 61; GFR African American, estimated mL/min/1.73m2 : 74; CO2 content mEq/L : 29<br/>
<br/>
(12/13/2022) CEA ng/mL : 1.0; CA 27-29 U/mL : 90.2 (H)<br/>
<br/>
(12/13/2022) TSH uIU/mL : 0.03 Critical Value Verified x 2 (LL); T3, free pg/mL : 3.0; T4, free ng/dL : 1.63<br/>
<br/>
<br/>Assessment:

<br/>
<br/>
<ol><li>Non-small cell lung cancer</li><li>Concurrent breast cancer</li><li>Hypothyroidism</li><li>Hyponatremia<br/>
	</li><li>Dementia  with memory loss (husband who has power of attorney, is with her to make decisions).</li><li>History of atrial arrhythmia requiring anticoagulation with Eliquis</li></ol>
<br/>
<br/>Plan:
Unclear etiology of the elevated liver function test, monitor closely.  May be related to medicines, continue to encourage hydration, follow clinically.  If not improved, may need additional evaluation by GI and/or scans.<br/>
<br/>
She has concurrent breast cancer along with non-small cell lung cancer, remains on Tagrisso for the lung cancer, and remains on exemestane for breast cancer.  Both cancers appear to be well controlled based on the last set of scans, thus we will continue clinically the medicines.<br/>
<br/>
Remains on anticoagulation with Eliquis, continue.  Being dosed by cardiology for atrial fibrillation.<br/>
<br/>
Hyponatremia is stable to improved, oral supplementation to continue as needed.<br/>
<br/>
Ultrasound to be ordered to ensure that there is no acute pathology in the liver.<br/>
<br/>
Husband has power of attorney is with her as patient unable to totally comprehend of what was explained to her secondary to dementia.<br/>
<br/>
All questions were answered, plan is otherwise as per order set.<br/>
<br/>
<br/>New Orders:<br/>
Labs:
<ul><li>12/20/2022, CA 27-29 panel, Perform Date: Prior to Next Visit</li><li>12/20/2022, CBC w/ auto diff, Perform Date: Prior to Next Visit</li><li>12/20/2022, CEA panel, Perform Date: Prior to Next Visit</li><li>12/20/2022, CMP, Perform Date: Prior to Next Visit</li><li>12/20/2022, Hemoglobin A1c panel, Perform Date: Prior to Next Visit</li><li>12/20/2022, Lipid panel, Perform Date: Prior to Next Visit</li><li>12/20/2022, T3, free panel, Perform Date: Prior to Next Visit</li><li>12/20/2022, T4, free panel, Perform Date: Prior to Next Visit</li><li>12/20/2022, TSH panel, Perform Date: Prior to Next Visit</li></ul>
<br/>
Services:
<ul><li>12/20/2022, Blood draw via port, Instructions: fasting am , Perform Date: Prior to Next Visit</li><li>12/20/2022, RTC MD/NP, Perform Date: 6 Weeks</li><li>12/20/2022, RTC nurse for injection, Instructions: prolia, Perform Date: 12/20/2022</li></ul>
<br/>
Imaging:
<ul><li>12/20/2022, U/S, Instructions: abdomen - eval abnormal LFT/s , Perform Date: ASAP</li></ul>
<br/>
Prescriptions: None<br/>
<br/>
<br/>Radiology:<br/>
<br/>
No recent imaging. <br/>
<br/>
<br/>Medications:<br/>

<ul><li>Folic Acid Oral</li><li>Midodrine Oral</li><li>Multivitamins Oral Tablet</li><li>Venlafaxine Oral</li><li>Calcium Carbonate Oral Chewable</li><li>Fexofenadine Oral</li><li>Famotidine Oral</li><li>Levothyroxine Oral</li><li>Magnesium Oxide Oral</li><li>Metoprolol Oral 24 hr Tab (Succinate)</li><li>Calcitriol Oral</li><li>Lipo-flavonoid plus, po solid (bioflav,lemon/vit bcomp,c)</li><li>Omega 3 Fatty Acids-Fish Oil Oral 300 mg-1,000 mg</li><li>Biotin Oral</li><li>Krill oil, po solid (krill/om3/dha/epa/om6/lip/astx)</li><li>Aromasin (Exemestane Oral)</li><li>Tagrisso, po solid (Osimertinib Oral)</li><li>Atorvastatin Oral</li><li>Coenzyme Q10 Oral</li><li>Furosemide Oral</li><li>Potassium Chloride Oral ER Tab</li><li>Pseudoephedrine-Guaifenesin Oral 12 hr Tab 60 mg-600 mg</li><li>Aricept (Donepezil Oral)</li><li>Sodium Chloride Oral</li><li>Apixaban Oral</li><li>Cholecalciferol Oral</li><li>Vit C,E-Zn-Copper-Lutein-Zeaxan Oral 250 mg-90 mg-40 mg-1 mg</li></ul>
<br/>Past Medical History:<br/>
atrial fibrillation, hypertension, hiatal hernia, hypercholesterolemia, hyperlipidemia, hypothyroidism, breast cancer, thyroid cancer
<ul><li>Left Ankle Fx 2021</li><li>Rt Wrist Fx 2021</li></ul>
Previous surgery: hysterectomy, 1965, TAH-BSO( cervical cancer), mastectomy, simple, 05/13/2020, Left breast, Left sentinel lymph node biopsy, modified radical mastectomy, 12/1999, Right breast, thyroidectomy, 2010, other:, Breast Augmentation- 1970's, Cataracts(both)- 2005, Bilat Feet Sx- 2009, AICD - Defibrillator- 2014,- BSO - 1965 - CERVICAL Cancer

<ul><li>Vocal Cord Sx</li><li>Right MRM</li><li>AICD - Defibrillator</li><li>TAH - BSO - 1965 - CERVICAL Cancer</li><li>Bilat Feet Sx</li><li>Breast Augmentation</li><li>Vocal Cord Sx</li><li>Left MRM - 2020</li></ul>
Health Maintenance<br/>
Preventive care &amp; screening.<br/>
Tobacco history: never smoker.<br/>
<br/>
Ob/Gyn History<br/>
Ob/Gyn History.<br/>
Pregnancy history: gravida: 3, para: 3, H/O breastfeeding: no.<br/>
Details: age at first menses, 16 years, last menstrual period, 1965, age at first live birth, 19 years, menopausal status, postmenopausal.<br/>
Ob/Gyn medication history: HRT: no history of HRT use, birth control: no history of birth control use.<br/>
<br/>
Family History<br/>
Mother: Deceased, cause of death: Blood disease, age at death: 39 years.<br/>
Father: Deceased, cause of death: cancer, lung cancer, age at death: Unknown.<br/>
<br/>
Social History<br/>
Married,<br/>
3 kids<br/>
Secretary<br/>
retired, alcohol use: rare, drugs of abuse: none, social support network: local family members available for support.<br/>
<br/>
*Social History:<br/>
Married,<br/>
3 kids<br/>
Secretary<br/>
retired, alcohol use: rare, drugs of abuse: none, social support network: local family members available for support.<br/>
<br/>
<br/>Problems:<br/>

<ul><li>Non-small cell lung cancer (disorder)</li><li>Abdominal aortic aneurysm (disorder)</li><li>Anxiety (finding)</li><li>Atrial arrhythmia (disorder)</li><li>Cancer antigen 27-29 above reference range (finding)</li><li>Chronic kidney disease (disorder)</li><li>Depressive disorder (disorder)</li><li>Essential hypertension (disorder)</li><li>Estrogen receptor negative status [ER-]</li><li>Estrogen receptor positive status [ER+]</li><li>Estrogen receptor positive status [ER+]</li><li>Fatigue (finding)</li><li>Gastroesophageal reflux disease (disorder)</li><li>Hyperlipidemia (disorder)</li><li>Hyponatremia (disorder)</li><li>Hypothyroidism (disorder)</li><li>Long-term current use of anticoagulant (situation)</li><li>Orthostatic hypotension (disorder)</li><li>Osteoporosis (disorder)</li><li>Primary malignant neoplasm of female breast (disorder)</li><li>Primary malignant neoplasm of thyroid gland (disorder)</li><li>Secondary malignant neoplasm of lung (disorder)</li><li>Tremor (finding)</li><li>Vitamin D deficiency (disorder)</li></ul>
<br/>Allergies and Adverse Reactions:<br/>

<ul><li>Adhesive tape</li><li>Benzodiazepines</li><li>Iodinated Contrast- Oral and IV Dye</li><li>Opioids-Meperidine and Related</li><li>Steri-strips</li><li>alcohol antiseptic pads</li><li>baclofen</li><li>meperidine HCl</li></ul>
<br/>
<br/>
Certainly if any new signs or symptoms develop pertaining to the illness that we are treating, advised to let us know immediately or report to the emergency room at the hospital depending on the severity of the problem.<br/>
<br/>
   <br/>


<br/>As always, the entire treatment plan and therapy to include chemotherapy, immunotherapy, IV infusions, hormonal therapy, any prescribed medicines were explained in detail to the patient and/or family members and friends.  Any and all questions were answered.  Risks, benefits, alternatives, and complications, to include the possibility of unknown side-effects, allergic type reactions, and organ damage that could be permanent in nature, to include the possibility of death itself from the treatment and/or its related side effects were reviewed.  The patient family verbalized understanding of what was explained to them and are agreeable with the plan as described above.  This transcription has not been edited and is subject to transcription/scribe variance.<br/>
<br/>
RUPESH J. PARIKH, MD<br/>
<br/>
Send copy of note to: Dijana, Jefic, M.D.<br/>
Kenneth Mooney, M.D.<br/>
Robert Ritchey, M.D.<br/>
Steven Fan Zhang, D.O.<br/>
<br/>
This document serves as a record of the services and decisions personally performed and made by Rupesh Parikh, MD. It was created on his behalf by Maria Duenas, a trained medical scribe. The creation of this document is based on the provider's statements to the medical scribe.<br/>
<br/>
The information in this document, created by the medical scribe for me, accurately reflects the services I personally performed, and the decisions made by me. I have reviewed and approved this document for accuracy prior to leaving the patient care area.<br/>
<br/>
<br/>

<br/>Electronically signed by Rupesh J. Parikh MD 12/28/2022 15:38 PST 
		        </p>
		      </li><li>
		        Nurse Note for: 24-JAN-23: 
		        <p>
		        		Comprehensive Cancer Center of Nevada<br/>Nurse Note<br/>Print Location: Unknown<br/>Date/Time Printed: 07/29/2024 13:50 (America/Los_Angeles)<br/>Patient: ROHDA, SANDIMARI P     Sex: Female      DOB: 10/16/1939      MRN:  1524290<br/>Date of Service: 01/24/2023<br/>Allergies :<br/>Opioids-Meperidine and Related, meperidine HCl, Iodinated Contrast- Oral and IV Dye, Benzodiazepines, baclofen, alcohol antiseptic pads, Adhesive tape, Steri-strips<br/>Vital Signs :<br/>Time: 11:54. Weight: 148.4 lb (67.31 kg). Height: 64 in (162.56 cm). BMI: 25.47 (kg/m2) . BSA: 1.72 (m2) . Temperature: 95.8 (F)  forehead. Pulse: 80 (/min)  brachial sitting. Respirations: 16 (/min) . Blood pressure: 118/81 (mm Hg) left arm Regular. Pain Scale: 0. O2 Saturation: 97 (%)  at rest.  Entered by Taylor McKnight MA 01/24/2023 11:55<br/>Time: 00:00. Pain Scale: 0.  Entered by Pierre Valentini RN Sr 01/24/2023 11:55<br/>Patient Assessment :<br/>Negative results Assessment :<br/>Labs Verified: No, Alert, oriented with appropriate behavior, Gait Changes. <br/>Denies Neuropathy , Pain -0-No pain, Fatigue , Anxiety/Depression , Fever, Chills or Night Sweats , Signs of Infection , Skin Changes , Dizziness , Headaches , Nausea , Breathing Changes , Cough , Mouth Sores/Stomatitis/Mucositis , Changes in Appetite , Vomiting , Diarrhea , Constipation , Urinary Changes , Bleeding . <br/>Entered By Pierre Valentini RN Sr on 11:55<br/>IV Access/Lab Draw :<br/>IV Access-CVC - Port-A-Cath, Needle Type-Huber, Needle Size-20 Gauge, Needle Length-1 inch, Access Site-Right Arm, Flush-10ml NS, Site Assess List-Blood Return,No Redness,No Swelling,No Tenderness,No Bruising, <br/>Entered By Pierre Valentini RN Sr on 11:56<br/>IV De-Access :<br/>IV Access Method-CVC - Port-A-Cath, IV Access Type-Huber, Line Flushed-20ml NS,500u Heparin, Catheter-Dc'd, Site Care-Site Dressing Applied,Port Deaccessed, Site Assess-Line Intact,No Redness,No Swelling,No Tenderness,No Bruising, <br/>Entered By Pierre Valentini RN Sr on 11:56<br/>Procedures :<br/>Blood draw via port - Associated Problem(s): Non-small cell lung cancer (disorder) *; Selected Billing Code(s): COLLECT BLOOD FROM IMPLANT VENOUS ACCESS DEVICE (36591)<br/>Entered By Pierre Valentini RN Sr; Incident to Parikh, Rupesh J., MD<br/> 
		        </p>
		      </li><li>
		        Nurse Note for: 20-DEC-22: 
		        <p>
		        		Comprehensive Cancer Center of Nevada<br/>Nurse Note<br/>Print Location: Unknown<br/>Date/Time Printed: 07/29/2024 13:50 (America/Los_Angeles)<br/>Patient: ROHDA, SANDIMARI P     Sex: Female      DOB: 10/16/1939      MRN:  1524290<br/>Date of Service: 12/20/2022<br/>Allergies :<br/>Opioids-Meperidine and Related, meperidine HCl, Iodinated Contrast- Oral and IV Dye, Benzodiazepines, baclofen, alcohol antiseptic pads, Adhesive tape, Steri-strips<br/>Vital Signs :<br/>Time: 12:41. Weight: 146.8 lb (66.59 kg). Height: 64 in (162.56 cm). BMI: 25.2 (kg/m2) . BSA: 1.72 (m2) . Temperature: 98.2 (F)  forehead. Pulse: 80 (/min) . Respirations: 16 (/min) . Blood pressure: 104/70 (mm Hg) left arm Regular. Pain Scale: 0. O2 Saturation: 95 (%)  at rest.  Entered by Erika Santamaria 12/20/2022 12:43<br/>Patient Assessment :<br/>Negative results Assessment :<br/>Denies Pain -0-No pain. <br/>Medication Administration :<br/>Incident to: Parikh, Rupesh, MD<br/>Denosumab (Prolia) Q6Month<br/>Immunotherapy<br/>Denosumab Subcutaneous (60 mg/mL - Prolia), 60 mg subcutaneously, Instructions: Administer SQ injection in the upper arm, upper thigh or abdomen., Allow Substitution<br/>     GIVEN: 60 mg<br/>     Pharmacy plan: Dispense/Waste: 60/0 mg<br/>     Pharmacy dispense: NDC: 55513071001 Dispense/Waste: 60/0 mg<br/>     Given Dose/Discard: 60/0 mg<br/>     Admin Details: Injection Location: Left-Upper Arm<br/>     Time: 13:25<br/>     Double Checked By: Cherie Allison RN Sr on 12/20/2022 13:27 and Taylor Mcknight MA on 12/20/2022 14:41<br/> 
		        </p>
		      </li></ul>
</div><br/><br/></body></html>